FPF
NBIX icon

First Pacific Financial’s Neurocrine Biosciences NBIX Stock Holding History

First Pacific Financial’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34
Closed -$4.69K – 445
2024
Q1 		$4.69K Buy
34
+10
+42% +$1.37K ﹤0.01% 298
2023
Q4 		$3.16K Buy
+24
New +$2.76K ﹤0.01% 291

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

First Pacific Financial's NBIX Position: Q2 2024 in Review

First Pacific Financial sold out of Neurocrine Biosciences (NBIX) in Q2 2024, closing a stake of 34 shares — an estimated $4.69K sold.

First Pacific Financial first reported a position in NBIX in Q4 2023 and held it in 2 quarters. The position peaked at $4.69K in Q1 2024. 594 funds tracked by Wall St. Rank hold NBIX as of Q2 2024.

  • First Pacific Financial reported no remaining Neurocrine Biosciences position as of Q2 2024 after selling out during the quarter.
  • First Pacific Financial sold 34 Neurocrine Biosciences shares in Q2 2024, an estimated $4.69K.
  • First Pacific Financial first reported a position in Neurocrine Biosciences in Q4 2023 and held it in 2 quarters.
  • First Pacific Financial's Neurocrine Biosciences position peaked at $4.69K in Q1 2024.
  • 594 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2024.

Based on First Pacific Financial's 13F filing for Q2 2024, filed 19 Jul 2024.